Table 3.
NHANES |
1988–1994 (n=16573) | 1999–2000 (n=4222) | 2001–2002 (n=4792) | 2003–2004 (n=4742) | 2005–2006 (n=4481) | 2007–2008 (n=5660) | 2009–2010 (n=6011) | 2011–2012 (n=5281 | 2013–2014 (n=5541) | P for trend‡ |
No. with 3 or more comorbidities* | 4975 | 1591 | 1678 | 1893 | 1705 | 2349 | 2366 | 1996 | 2202 | |
Overall prevalence (%)± | 24.6 (23.2–25.9) | 30.5 (27.5–33.5) | 29.2 (26.8–31.6) | 34.2 (31.5–36.9) | 34.2 (31.5–36.9) | 34.7 (32.1–37.4) | 33.8 (31.9–35.8) | 34.7 (31.3–38.1) | 38.5 (36.3–40.6) | <.0001 |
Unweighted total number of subjects with 3 or more multi-morbidities
Weighted overall prevalence of 3 or more multi-morbidities
p-value from logistic regression analysis.
Chronic conditions included in determining multi-morbidity: cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), asthma, arthritis, cancer, stroke, hypertension, hyperlipidemia, diabetes, and obesity.